Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Biocidal product factsheet - Last updated: 29/05/2024
Biocidal product factsheet
Trade name:
-
Brodifacoum (bloky 25 ppm) – profesionální použití
Brodifacoum 25 ppm Blocks - Professional
Brodifacoum 25 ppm Blocks - Professional Use
BRODIFACOUM 25 PPM BLOCKS – PROFESSIONAL USE
Brodifacoum 25ppm Blocks - Professional and Non-Professional Use
BRODIFACOUM 25ppm rágcsálóirtó blokk (szakképzett és lakossági felhasználás)
Brodikill Bloque 25
Final 25 Blox
FINAL 25 rágcsálóirtó blokk
Final25 Blox
Jaguar 25 Blox
JAGUAR 25 rágcsálóirtó blokk
Latigo Plus Bloque
Roe-Block Forte
Solo 25 Blox
SOLO 25 rágcsálóirtó blokk
Product-type:
PT14
Substance name:
IUPAC name:
3-[3-(4'-bromobiphenyl- 4-yl)-1,2,3,4-tetrahydro -1-napthyl]-4-hydroxycoumarin
EC number:
259-980-5
CAS number:
56073-10-0
BAS number:
11
The Active Substance is a candidate for substitution
Authorisation type:
National authorisation
Legal act:
Assessment reports:
Authorisation number | SPC | Decisions | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
- |
Netherlands |
Bell Laboratories Netherlands B.V. | NL-0017725-0000 | - | 05/04/2019 | 01/07/2025 |
20221212 - Bell Laboratories- amendment.pdf (nl) 20221230_NL-0017725-0000_Decision.pdf (nl) |
Authorised | ||
- |
Austria |
Bell Laboratories Netherlands B.V. | AT-0021635-0000 | AT-0021635-0000 | 05/04/2019 | 01/07/2025 |
Brodifacoum_25_ppm_Blocks_-_Professional Use_Bescheid_BMNT-UW.1.2.5_0601-V_5_2019.pdf (de) Brodifacoum_25_ppm_Blocks_-_Professional_Use_Anlage_1.pdf (de) |
Authorised | ||
Final 25 Blox Jaguar 25 Blox Solo 25 Blox |
PT14
|
Belgium |
Bell Laboratories Netherlands B.V. | BE-0021324-0000 | BE2019-0072 | 05/04/2019 | 01/07/2024 |
|
BE2019-0072_ACT.pdf (fr) |
Authorised |
- |
PT14
|
Croatia |
Bell Laboratories Netherlands B.V. | HR-0030366-0000 | KLASA:UP/I-543-04/22-12/35 | 31/01/2023 | 01/07/2024 |
rjesenje_Brodifacoum 25ppm Blocks - Professional and Non-Professional Use_HR.pdf (hr) |
Authorised | |
Brodifacoum (bloky 25 ppm) – profesionální použití Final 25 Blox Jaguar 25 Blox Solo 25 Blox |
PT14
|
Czech Republic |
Bell Laboratories Netherlands B.V. | CZ-0030302-0000 | CZ-0030302-0000 | 12/06/2023 | 01/07/2024 | Authorised | ||
BRODIFACOUM 25 PPM BLOCKS – PROFESSIONAL USE FINAL25 BLOX JAGUAR 25 BLOX SOLO 25 BLOX |
PT14
|
France |
Bell Laboratories Netherlands B.V. | FR-0021232-0000 | FR-2020-0004 | 31/01/2020 | 01/07/2024 |
BRODIFACOU_BC-YJ051711-30_NA-MRS_D.pdf (fr) |
Authorised | |
- |
Germany |
Bell Laboratories Netherlands B.V. | DE-0021834-0000 | DE-0021834-14 | 20/03/2020 | 01/07/2025 | Authorised | |||
Final25 Blox Jaguar 25 Blox Solo 25 Blox |
PT14
|
Greece |
Bell Laboratories Netherlands B.V. | GR-0021488-0000 | ΤΠ14-0156 | 16/08/2019 | 01/07/2024 |
SOLO-BLOCK_25_EXT._JANUARY_2023s.pdf (el) SOLO BLOX 25_VAR FEBRUARY 2023.pdf (el) SOLO BLOX 25 MRP.pdf (el) |
Authorised | |
BRODIFACOUM 25ppm rágcsálóirtó blokk (szakképzett és lakossági felhasználás) FINAL 25 rágcsálóirtó blokk JAGUAR 25 rágcsálóirtó blokk SOLO 25 rágcsálóirtó blokk |
PT14
|
Hungary |
Bell Laboratories Netherlands B.V. | HU-0030387-0000 | HU-2023-MA-14-00440-0000 | 03/02/2023 | 01/07/2024 | Authorised | ||
Jaguar 25 Blox Solo 25 Blox |
PT14
|
Ireland |
Bell Laboratories Netherlands B.V. | IE-0022150-0000 | IE/BPA 70784 | 05/04/2019 | 01/07/2024 | Authorised | ||
- |
Italy |
Bell Laboratories Netherlands B.V. | IT-0023907-0000 | IT/2020/00653/MRS | 05/04/2019 | 31/12/2026 |
Blocchi di Brodifacoum da 25 mg.pdf (it) |
Authorised | ||
Brodifacoum 25 ppm Blocks - Professional Brodifacoum 25ppm Blocks - Professional and Non-Professional Use Final 25 Blox Jaguar 25 Blox Solo 25 Blox |
PT14
|
Luxembourg |
Bell Laboratories Netherlands B.V. | LU-0030298-0000 | 36/23/L-000 | 03/03/2023 | 01/07/2024 |
AMM__Brodifacoum25ppmBlocksProfessionalandNonProfessionalUse.pdf (fr) |
Authorised | |
- |
PT14
|
Poland |
Bell Laboratories Netherlands B.V. | PL-0030154-0000 | PL/2023/0601/MR | 05/04/2019 | 01/07/2024 | Authorised | ||
- |
Slovenia |
Bell Laboratories Netherlands B.V. | SI-0030245-0000 | SI-0030245-0000 | 09/01/2023 | 01/07/2025 | Authorised | |||
Brodikill Bloque 25 Final 25 Blox Jaguar 25 Blox Latigo Plus Bloque Roe-Block Forte Solo 25 Blox |
PT14
|
Spain |
Bell Laboratories Netherlands B.V. | ES-0021773-0000 | ES/MR(NA)-2020-14-00680 | 22/01/2020 | 01/07/2024 |
R4BP3-ES-0021773-0000-Authorisation.pdf (es) R4BP3-ES-0021773-0000-Authorisation.pdf (es) R4BP-ES-0021773-0000-Authorisation.pdf (es) |
Authorised | |
Final25 Blox Jaguar 25 Blox Solo 25 Blox |
PT14
|
Switzerland |
Bell Laboratories Netherlands B.V. | CH-0022167-0000 | CH-2020-0004 | 28/01/2020 | 01/07/2024 | Authorised | ||
Brodifacoum 25 ppm Blocks - Professional Use Jaguar 25 Blox Solo 25 Blox |
PT14
|
United Kingdom |
Bell Laboratories UK Ltd | UK-0021302-0000 | UK-2020-1239 | 16/03/2020 | 31/12/2020 |
SPC not available |
Expired |
Authorisation number: NL-0017725-0000| Market area: Netherlands
6 assessment records available
Evaluating authority:
Netherlands
Conclusion date:
22/12/2022
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Netherlands
Conclusion date:
13/12/2022
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Netherlands
Conclusion date:
14/02/2020
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Evaluating authority:
Netherlands
Conclusion date:
05/11/2019
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Evaluating authority:
Netherlands
Conclusion date:
02/04/2019
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Authorisation number: AT-0021635-0000| Market area: Austria
3 assessment records available
Evaluating authority:
Austria
Conclusion date:
26/01/2023
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Austria
Conclusion date:
30/10/2019
Start date:
23/10/2019
End date:
05/04/2024
SPC not available
Authorisation number: BE-0021324-0000| Market area: Belgium
5 assessment records available
Evaluating authority:
Belgium
Conclusion date:
20/01/2023
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Evaluating authority:
Belgium
Conclusion date:
22/01/2020
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Evaluating authority:
Belgium
Conclusion date:
20/01/2020
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Evaluating authority:
Belgium
Conclusion date:
15/01/2020
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Authorisation number: CZ-0030302-0000| Market area: Czech Republic
Authorisation number: FR-0021232-0000| Market area: France
4 assessment records available
Evaluating authority:
France
Conclusion date:
14/11/2022
Start date:
31/01/2020
End date:
01/07/2024
SPC not available
Evaluating authority:
France
Conclusion date:
03/02/2020
Start date:
31/01/2020
End date:
05/04/2024
SPC not available
Evaluating authority:
France
Conclusion date:
31/01/2020
Start date:
31/01/2020
End date:
04/04/2024
SPC not available
Authorisation number: DE-0021834-0000| Market area: Germany
3 assessment records available
Evaluating authority:
Germany
Conclusion date:
21/03/2024
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Germany
Conclusion date:
12/03/2020
Start date:
12/03/2020
End date:
05/04/2024
SPC not available
Authorisation number: GR-0021488-0000| Market area: Greece
3 assessment records available
Evaluating authority:
Greece
Conclusion date:
20/01/2023
Start date:
16/08/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Greece
Conclusion date:
12/09/2019
Start date:
16/08/2019
End date:
05/04/2024
SPC not available
Authorisation number: HU-0030387-0000| Market area: Hungary
2 assessment records available
Evaluating authority:
Hungary
Conclusion date:
03/02/2023
Start date:
03/02/2023
End date:
01/07/2024
SPC not available
Authorisation number: IE-0022150-0000| Market area: Ireland
2 assessment records available
Evaluating authority:
Ireland
Conclusion date:
27/01/2020
Start date:
27/01/2020
End date:
05/04/2024
SPC not available
Authorisation number: IT-0023907-0000| Market area: Italy
4 assessment records available
Evaluating authority:
Italy
Conclusion date:
15/05/2023
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Italy
Conclusion date:
11/11/2022
Start date:
05/04/2019
End date:
01/07/2024
SPC not available
Evaluating authority:
Italy
Conclusion date:
10/09/2020
Start date:
12/06/2020
End date:
05/04/2024
SPC not available
Authorisation number: LU-0030298-0000| Market area: Luxembourg
Authorisation number: SI-0030245-0000| Market area: Slovenia
2 assessment records available
Evaluating authority:
Slovenia
Conclusion date:
11/01/2023
Start date:
09/01/2023
End date:
01/07/2024
SPC not available
Authorisation number: ES-0021773-0000| Market area: Spain
6 assessment records available
Evaluating authority:
Spain
Conclusion date:
10/02/2023
Start date:
22/01/2020
End date:
01/07/2024
SPC not available
Evaluating authority:
Spain
Conclusion date:
02/09/2022
Start date:
22/01/2020
End date:
01/07/2024
SPC not available
Evaluating authority:
Spain
Conclusion date:
02/03/2020
Start date:
22/01/2020
End date:
05/04/2024
SPC not available
Evaluating authority:
Spain
Conclusion date:
02/03/2020
Start date:
22/01/2020
End date:
10/03/2020
SPC not available
Evaluating authority:
Spain
Conclusion date:
04/02/2020
Start date:
22/01/2020
End date:
10/03/2020
SPC not available
Authorisation number: CH-0022167-0000| Market area: Switzerland
4 assessment records available
Evaluating authority:
Switzerland
Conclusion date:
09/02/2023
Start date:
28/01/2020
End date:
01/07/2024
SPC not available
Evaluating authority:
Switzerland
Conclusion date:
29/01/2020
Start date:
28/01/2020
End date:
05/04/2024
SPC not available
Evaluating authority:
Switzerland
Conclusion date:
28/01/2020
Start date:
05/04/2019
End date:
05/04/2024
SPC not available
Authorisation number: UK-0021302-0000| Market area: United Kingdom
2 assessment records available
Evaluating authority:
United Kingdom
Conclusion date:
26/08/2020
Start date:
16/03/2020
End date:
05/04/2024
SPC not available
Evaluating authority:
United Kingdom
Conclusion date:
17/03/2020
Start date:
16/03/2020
End date:
05/04/2024
SPC not available